Received Aug 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | — | — |
patient had a titer for MMR-II done on 4/24/2025, which showed she was low, not consistent with immunity, below 13.5.; This spontaneous report was received from a health business professional regarding a 65-year-old female patient. The patient's medical history, historical drugs, known drug allergies, concurrent conditions, and concomitant therapies were not reported. On an unknown date (reported that it was assumed it was when the patient was a child), the patient was vaccinated with the first dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), lyophilizate and solvent for solution for injection, reconstituted with sterile diluent (DSM STERILE DILUENT) solution for injection, as a vaccination (volume of injection, anatomical location, route of administration, lot #, and expiration date were not reported). On 24-Apr-2025, the patient had a titer for Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) done, which showed she was low, not consistent with immunity, as it was below 13.5 (unit not reported). At the time of this report, she had not yet been re vaccinated, as she had concerns on receiving live virus, hence she had not recovered from the event. The causal relationship between the event and Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) was not provided. Lot# is being requested and will be submitted if received.
Sterile diluent
Test Date: 20250424; Test Name: titer for MMR-II; Result Unstructured Data: low, not consistent with immunity, below 13.5 (unit nit reported).